Anixa Biosciences Inc - ANIX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Chief Executive Officer | P | A | 3,000.0 | 2.75 | 8,250.0 | 665,000.0 | View | |
| Sep 14, 2026 | — | P | A | 10,000.0 | 2.73 | 27,300.0 | 996,967.0 | View | |
| Sep 11, 2026 | Chief Executive Officer | P | A | 5,000.0 | 2.76 | 13,800.0 | 662,000.0 | View | |
| Aug 03, 2026 | Chief Executive Officer | P | A | 5,000.0 | 3.47 | 17,350.0 | 657,000.0 | View | |
| Jul 29, 2026 | — | M | D | 6,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jul 29, 2026 | — | F | D | 5,428.0 | 3.46 | 18,780.88 | 135,572.0 | View | |
| Jul 29, 2026 | — | M | A | 6,000.0 | 3.13 | 18,780.0 | 141,000.0 | View | |
| Jul 28, 2026 | Chief Executive Officer | P | A | 5,000.0 | 3.44 | 17,200.0 | 652,000.0 | View | |
| Jul 27, 2026 | Chief Executive Officer | P | A | 3,188.0 | 3.37 | 10,743.56 | 647,000.0 | View | |
| Jul 27, 2026 | Chief Executive Officer | P | A | 3,000.0 | 3.73 | 11,190.0 | 643,812.0 | View | |
| Jul 21, 2026 | Chief Executive Officer | P | A | 5,000.0 | 3.46 | 17,300.0 | 640,812.0 | View | |
| Jul 20, 2026 | — | P | A | 12,000.0 | 3.47 | 41,640.0 | 986,967.0 | View | |
| Jul 16, 2026 | — | P | A | 2,797.0 | 3.28 | 9,174.16 | 974,967.0 | View | |
| Jul 13, 2026 | Chief Executive Officer | P | A | 5,000.0 | 3.04 | 15,200.0 | 635,812.0 | View | |
| Jun 17, 2026 | — | P | A | 2,836.0 | 2.64 | 7,487.04 | 972,170.0 | View | |
| Jun 16, 2026 | Chief Executive Officer | P | A | 21,000.0 | 2.5 | 52,500.0 | 630,812.0 | View |